Clinical trial
Effect of GLP-1 on Angiogenesis, Angiosafe Type 2 Diabetes Study 1
NCT02686177 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of GLP-1 on Angiogenesis, Angiosafe Type 2 Diabetes Study 1
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 18, 2016
- Completion date
- May 28, 2021
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes